$COLL
COLLEGIUM PHARMACEUTICAL, INC

2021 Q2 Form 10-Q Financial Statement

#000155837021010562 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $82.94M $78.06M
YoY Change 6.26% 4.02%
Cost Of Revenue $32.70M $29.69M
YoY Change 10.13% -38.97%
Gross Profit $50.24M $48.36M
YoY Change 3.88% 83.29%
Gross Profit Margin 60.57% 61.96%
Selling, General & Admin $30.37M $29.32M
YoY Change 3.57% 1.34%
% of Gross Profit 60.45% 60.63%
Research & Development $3.462M $2.493M
YoY Change 38.87% 1.38%
% of Gross Profit 6.89% 5.15%
Depreciation & Amortization $17.25M $17.00M
YoY Change 1.49% 335.9%
% of Gross Profit 34.34% 35.15%
Operating Expenses $33.83M $31.82M
YoY Change 6.33% 1.34%
Operating Profit $16.41M $16.55M
YoY Change -0.85% -430.45%
Interest Expense $5.421M $8.259M
YoY Change -34.36% 3399.58%
% of Operating Profit 33.04% 49.91%
Other Income/Expense, Net
YoY Change
Pretax Income $10.99M $8.304M
YoY Change 32.36% -276.23%
Income Tax -$61.85M $246.0K
% Of Pretax Income -562.75% 2.96%
Net Earnings $72.84M $8.058M
YoY Change 803.98% -271.01%
Net Earnings / Revenue 87.82% 10.32%
Basic Earnings Per Share $2.06 $0.23
Diluted Earnings Per Share $1.79 $0.23
COMMON SHARES
Basic Shares Outstanding 35.30M 34.40M
Diluted Shares Outstanding 41.29M 35.09M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $202.8M $145.7M
YoY Change 39.17% -2.02%
Cash & Equivalents $202.8M $145.7M
Short-Term Investments
Other Short-Term Assets $6.068M $5.100M
YoY Change 18.98% 10.87%
Inventory $19.60M $18.82M
Prepaid Expenses
Receivables $90.10M $81.20M
Other Receivables $0.00 $0.00
Total Short-Term Assets $318.5M $250.8M
YoY Change 27.0% 2.56%
LONG-TERM ASSETS
Property, Plant & Equipment $19.56M $15.16M
YoY Change 29.02% 46.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $115.0K $163.0K
YoY Change -29.45% -17.68%
Total Long-Term Assets $395.2M $396.1M
YoY Change -0.22% 594.62%
TOTAL ASSETS
Total Short-Term Assets $318.5M $250.8M
Total Long-Term Assets $395.2M $396.1M
Total Assets $713.7M $646.9M
YoY Change 10.34% 114.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.543M $8.182M
YoY Change -7.81% -25.22%
Accrued Expenses $27.39M $25.11M
YoY Change 9.06% 2.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $47.92M $47.10M
YoY Change 1.74% 2378.95%
Total Short-Term Liabilities $226.8M $252.1M
YoY Change -10.02% 28.45%
LONG-TERM LIABILITIES
Long-Term Debt $225.5M $229.9M
YoY Change -1.93% 2294.79%
Other Long-Term Liabilities $8.371M $9.100M
YoY Change -8.01% -8.08%
Total Long-Term Liabilities $233.8M $239.0M
YoY Change -2.16% 1125.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $226.8M $252.1M
Total Long-Term Liabilities $233.8M $239.0M
Total Liabilities $460.7M $491.1M
YoY Change -6.2% 127.62%
SHAREHOLDERS EQUITY
Retained Earnings -$239.4M -$351.4M
YoY Change -31.88% -0.06%
Common Stock $36.00K $34.00K
YoY Change 5.88% 3.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $253.1M $155.8M
YoY Change
Total Liabilities & Shareholders Equity $713.7M $646.9M
YoY Change 10.34% 114.49%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $72.84M $8.058M
YoY Change 803.98% -271.01%
Depreciation, Depletion And Amortization $17.25M $17.00M
YoY Change 1.49% 335.9%
Cash From Operating Activities $29.50M $43.90M
YoY Change -32.79% 198.64%
INVESTING ACTIVITIES
Capital Expenditures -$753.0K -$2.300M
YoY Change -67.26% 155.56%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$753.0K -$2.300M
YoY Change -67.26% 155.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.797M -12.20M
YoY Change -27.89%
NET CHANGE
Cash From Operating Activities 29.50M 43.90M
Cash From Investing Activities -753.0K -2.300M
Cash From Financing Activities -8.797M -12.20M
Net Change In Cash 19.95M 29.40M
YoY Change -32.13% 113.04%
FREE CASH FLOW
Cash From Operating Activities $29.50M $43.90M
Capital Expenditures -$753.0K -$2.300M
Free Cash Flow $30.26M $46.20M
YoY Change -34.51% 196.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35523917
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34612054
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001267565
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37372
dei Entity Registrant Name
EntityRegistrantName
Collegium Pharmaceutical, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0416362
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Technology Center Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Stoughton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02072
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
713-3699
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
COLL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35564465
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202771000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
174116000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90098000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
83320000
CY2021Q2 us-gaap Inventory Net
InventoryNet
19595000
CY2020Q4 us-gaap Inventory Net
InventoryNet
15614000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6068000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4838000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
318532000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
277888000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19555000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18988000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8023000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8391000
CY2021Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
302314000
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
335904000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
62649000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
115000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
123000
CY2021Q2 us-gaap Assets
Assets
713735000
CY2020Q4 us-gaap Assets
Assets
643841000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7543000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10016000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27386000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24656000
CY2021Q2 coll Accrued Rebates Returns And Discounts Current
AccruedRebatesReturnsAndDiscountsCurrent
143224000
CY2020Q4 coll Accrued Rebates Returns And Discounts Current
AccruedRebatesReturnsAndDiscountsCurrent
156554000
CY2021Q2 us-gaap Loans Payable Current
LoansPayableCurrent
47919000
CY2020Q4 us-gaap Loans Payable Current
LoansPayableCurrent
47495000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
771000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
730000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
226843000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
239451000
CY2021Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
85944000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
110019000
CY2021Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
139511000
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
99575000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8371000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8765000
CY2021Q2 us-gaap Liabilities
Liabilities
460669000
CY2020Q4 us-gaap Liabilities
Liabilities
457810000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35523917
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34612054
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
36000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
35000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
492384000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
519143000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239354000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-333147000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
253066000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
186031000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
713735000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
643841000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
82942000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78058000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170663000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
154569000
CY2021Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
15908000
CY2020Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
12899000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
31236000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
40128000
CY2021Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
16795000
CY2020Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
16795000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
33590000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
27090000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32703000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29694000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
64826000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
67218000
CY2021Q2 us-gaap Gross Profit
GrossProfit
50239000
CY2020Q2 us-gaap Gross Profit
GrossProfit
48364000
us-gaap Gross Profit
GrossProfit
105837000
us-gaap Gross Profit
GrossProfit
87351000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3462000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2493000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6392000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5159000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30368000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29322000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61844000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
60582000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
33830000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
31815000
us-gaap Operating Expenses
OperatingExpenses
68236000
us-gaap Operating Expenses
OperatingExpenses
65741000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
16409000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
16549000
us-gaap Operating Income Loss
OperatingIncomeLoss
37601000
us-gaap Operating Income Loss
OperatingIncomeLoss
21610000
CY2021Q2 us-gaap Interest Expense
InterestExpense
5421000
CY2020Q2 us-gaap Interest Expense
InterestExpense
8259000
us-gaap Interest Expense
InterestExpense
11142000
us-gaap Interest Expense
InterestExpense
13082000
CY2021Q2 us-gaap Investment Income Net
InvestmentIncomeNet
3000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
246000
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
14000
us-gaap Investment Income Net
InvestmentIncomeNet
6000
us-gaap Investment Income Net
InvestmentIncomeNet
226000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10991000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8304000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26465000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8754000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-61852000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
246000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-62040000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
72843000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
8058000
us-gaap Net Income Loss
NetIncomeLoss
88505000
us-gaap Net Income Loss
NetIncomeLoss
8508000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.06
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35302608
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34395266
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35128144
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34247977
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.79
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41286853
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35091906
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41251749
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35089740
us-gaap Net Income Loss
NetIncomeLoss
88505000
us-gaap Net Income Loss
NetIncomeLoss
8508000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33590000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27090000
us-gaap Depreciation
Depreciation
864000
us-gaap Depreciation
Depreciation
394000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-62649000
us-gaap Share Based Compensation
ShareBasedCompensation
13395000
us-gaap Share Based Compensation
ShareBasedCompensation
10535000
coll Operating Lease Payments Non Cash
OperatingLeasePaymentsNonCash
15000
coll Operating Lease Payments Non Cash
OperatingLeasePaymentsNonCash
36000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1795000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3860000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6778000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8242000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4498000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9785000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1301000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2005000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2472000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1935000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2969000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8645000
coll Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
-13330000
coll Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
13504000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
50105000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37185000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
368226000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1153000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1662000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1153000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-369888000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
358000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
357000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8274000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6080000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3929000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1922000
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
192117000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
138277000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
25000000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
12500000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
11500000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20297000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
310909000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
28655000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-21794000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176663000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170019000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
205318000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148225000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202771000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145678000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
205318000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148225000
us-gaap Interest Paid Net
InterestPaidNet
9348000
us-gaap Interest Paid Net
InterestPaidNet
8259000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
876000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
55000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
1555000
coll Noncash Or Part Noncash Acquisition Accrued Royalties Discharged
NoncashOrPartNoncashAcquisitionAccruedRoyaltiesDischarged
1145000
coll Inventory Used In Construction And Installation Of Property And Equipment
InventoryUsedInConstructionAndInstallationOfPropertyAndEquipment
516000
coll Inventory Used In Construction And Installation Of Property And Equipment
InventoryUsedInConstructionAndInstallationOfPropertyAndEquipment
613000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
82942000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78058000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170663000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
154569000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
72843000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
8058000
us-gaap Net Income Loss
NetIncomeLoss
88505000
us-gaap Net Income Loss
NetIncomeLoss
8508000
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1168000
us-gaap Interest Expense Debt
InterestExpenseDebt
2333000
CY2021Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
74011000
CY2020Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
8058000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
90838000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
8508000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35302608
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34395266
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35128144
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34247977
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41286853
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35091906
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41251749
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35089740
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.06
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.79
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
162337000
CY2021Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
139511000
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
6100000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3514000
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3995000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1096000
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9500000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11004000
CY2021Q2 us-gaap Inventory Net
InventoryNet
19595000
CY2020Q4 us-gaap Inventory Net
InventoryNet
15614000
CY2021Q2 coll Inventory Used In Construction And Installation Of Property And Equipment
InventoryUsedInConstructionAndInstallationOfPropertyAndEquipment
0
coll Inventory Used In Construction And Installation Of Property And Equipment
InventoryUsedInConstructionAndInstallationOfPropertyAndEquipment
516000
CY2020Q2 coll Inventory Used In Construction And Installation Of Property And Equipment
InventoryUsedInConstructionAndInstallationOfPropertyAndEquipment
219000
coll Inventory Used In Construction And Installation Of Property And Equipment
InventoryUsedInConstructionAndInstallationOfPropertyAndEquipment
613000
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
521170000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
521170000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
218856000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
185266000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
302314000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
335904000
coll Summary Of Costs Included In Acquired Asset
SummaryOfCostsIncludedInAcquiredAsset
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:28.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Acquisition consideration:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Base purchase price</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:28.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 375,000</p></td></tr><tr><td style="vertical-align:bottom;width:68.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Cash paid for inventory</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 6,030</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Transaction costs</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:28.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 6,297</p></td></tr><tr><td style="vertical-align:bottom;width:68.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Reduction for 2020 cash transferred to Assertio under the prior Nucynta Commercialization Agreement<sub style="font-size:7.5pt;vertical-align:sub;">(1)</sub></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (13,071)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Reduction for accrued royalty obligation discharged upon closing<sub style="font-size:7.5pt;vertical-align:sub;">(1)</sub></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:28.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (1,145)</p></td></tr><tr><td style="vertical-align:bottom;width:68.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total acquisition consideration:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 373,111</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">Represents </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">$14,216</span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;"> total reduction to the base purchase price comprising of </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;">$13,071</span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;text-align:left;"> of cash payments transferred to Assertio under the prior Nucynta Commercialization Agreement as well as a reduction for discharged pre-acquisition accrued royalties based on sales from January 1, 2020 through closing. </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Company then allocated the consideration transferred to the individual assets acquired on a relative fair value basis as summarized in the table below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:71.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:24.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets acquired:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Nucynta Intangible Asset</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:24.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 367,081</p></td></tr><tr><td style="vertical-align:bottom;width:71.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Inventory</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,030</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:71.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total consideration allocated to assets acquired:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:24.66%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 373,111</p></td></tr></table>
CY2018Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P4Y
CY2020Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y10M24D
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16795000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16795000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33590000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27090000
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P4Y6M
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
33591000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
67181000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
67181000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
67181000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
67180000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
302314000
CY2021Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
14312000
CY2020Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
12954000
CY2021Q2 coll Accrued Product Taxes And Fees Current
AccruedProductTaxesAndFeesCurrent
2205000
CY2020Q4 coll Accrued Product Taxes And Fees Current
AccruedProductTaxesAndFeesCurrent
1817000
CY2021Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1860000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4571000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1827000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
892000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1775000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
445000
CY2021Q2 coll Accrued Incentive Compensation Current
AccruedIncentiveCompensationCurrent
1504000
CY2020Q4 coll Accrued Incentive Compensation Current
AccruedIncentiveCompensationCurrent
1417000
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1415000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1415000
CY2021Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
839000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
261000
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
104000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1545000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
884000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27386000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24656000
CY2020Q4 coll Debt Instrument Initial Carrying Amount Of Liability Component
DebtInstrumentInitialCarryingAmountOfLiabilityComponent
97200000
CY2020Q4 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
46550000
CY2020 us-gaap Debt Instrument Convertible Remaining Discount Amortization Period1
DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
P6Y
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
186031000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4102000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
358000
CY2021Q1 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-3508000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6879000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
15662000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
170035000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4093000
CY2021Q2 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-421000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6516000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
72843000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
253066000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
87432000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4454000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
357000
CY2020Q1 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue
-1358000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4951000
CY2020Q1 coll Adjustments To Additional Paid In Capital Convertible Debt Equity Component Of Transaction Costs
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtEquityComponentOfTransactionCosts
1773000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
44777000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
450000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
141063000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1626000
CY2020Q2 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue
-564000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5584000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
8058000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
155767000
CY2021Q2 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
8043000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-5.628
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.030
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-2.344
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.672
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.661
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6516000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5584000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13395000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10535000
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
56389000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-61852000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
246000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-62040000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
246000
coll Positive Earnings Minimum Period
PositiveEarningsMinimumPeriod
P3Y
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-62649000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.028
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1966000

Files In Submission

Name View Source Status
0001558370-21-010562-index-headers.html Edgar Link pending
0001558370-21-010562-index.html Edgar Link pending
0001558370-21-010562.txt Edgar Link pending
0001558370-21-010562-xbrl.zip Edgar Link pending
coll-20210630.xsd Edgar Link pending
coll-20210630x10q.htm Edgar Link pending
coll-20210630x10q001.jpg Edgar Link pending
coll-20210630x10q_htm.xml Edgar Link completed
coll-20210630xex10d1.htm Edgar Link pending
coll-20210630xex31d1.htm Edgar Link pending
coll-20210630xex31d2.htm Edgar Link pending
coll-20210630xex32d1.htm Edgar Link pending
coll-20210630xex32d2.htm Edgar Link pending
coll-20210630_cal.xml Edgar Link unprocessable
coll-20210630_def.xml Edgar Link unprocessable
coll-20210630_lab.xml Edgar Link unprocessable
coll-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending